Amylin name ex-Novartis CEO as chairman
This article was originally published in Scrip
Executive Summary
Amylin Pharmaceuticals has elected former Novartis US president and CEO Paulo Costa as chairman of its board. Mr Costa will join Amylin immediately following a unanimous decision by board directors and he has set his sights on expanding the firm's diabetes care.